NCT02888951

Brief Summary

This study evaluates the amount of fluid remaining in the stomach of diabetic patients after a standard fasting period, and compare it with non-diabetic patients coming for elective surgical procedures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

August 22, 2016

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 5, 2016

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
Last Updated

January 18, 2020

Status Verified

February 1, 2019

Enrollment Period

4.4 years

First QC Date

August 22, 2016

Last Update Submit

January 14, 2020

Conditions

Keywords

DiabetesDiabetes MellitusGastric UltrasoundPreoperative fastingEmpty StomachGastric Diabetes

Outcome Measures

Primary Outcomes (1)

  • Volume of Gastric Contents

    A "full stomach" is defined as one containing a) solid or thick fluid content or b) \> 1.5 mL/kg of clear fluid. There are 4 categories regarding gastric contents: 1. Empty Stomach 2. Grade 1 Clear Fluid (fluid only observed in supine or right lateral decubitus position) 3. Grade 2 Clear Fluid (fluid only observed in both supine and right lateral decubitus position) 4. Solid

    Less than two hour prior to surgery

Secondary Outcomes (5)

  • Distribution of baseline gastric volume in fasted diabetic and non-diabetic patients

    Less than two hour prior to surgery

  • Define the upper limit of normal fasting gastric volume defined as the 95th percentile

    Less than two hour prior to surgery

  • Duration and degree of glycemic control with baseline gastric fluid volume amongst diabetic patients

    Less than two hour prior to surgery

  • Gastric volume of diabetic patients in relation with the medication/therapy used manage their diabetes.

    Less than two hour prior to surgery

  • Episodes of intra-operative regurgitation, vomiting or aspiration

    Intraoperative

Study Arms (2)

Diabetic Group

A group of diabetic patients who have fasted for at least 8 hours undergoing an elective surgical procedure.

Non-Diabetic Group

A group of non-diabetic patients who have fasted for at least 8 hours undergoing an elective surgical procedure.

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study participants will be patients whom are scheduled to undergo elective surgical procedures requiring preoperative fasting period of at least 8 hours. 240 patients will be recruited in total. One cohort consisting 120 patients will be diabetic (type 1 or 2). The other cohort consisting of 120 patients will be non-diabetic.

You may qualify if:

  • Patients scheduled for elective surgery aged 18 to 85 years
  • American Society of Anesthesia physical status classification I to III
  • Body mass index \< 40 kg/ cm2.

You may not qualify if:

  • Pregnancy (currently or within the past 3 months)
  • Previous surgery of the upper gastrointestinal tract
  • Achalasia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Toronto Western Hospital

Toronto, Ontario, M5T 2S8, Canada

RECRUITING

MeSH Terms

Conditions

Diabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2016

First Posted

September 5, 2016

Study Start

August 1, 2016

Primary Completion

January 1, 2021

Study Completion

January 1, 2021

Last Updated

January 18, 2020

Record last verified: 2019-02

Locations